Seikagaku Weathers Another Quarter of Losses

Seikagaku's logo

Seikagaku reported 3Q20 orthopedic revenue of USD $32.8 million, -8.9% vs. 3Q19. The market forces impacting the company remain largely unchanged from last quarter. The company’s ARTZ viscosupplement continued to take market share in Japan, but decreases in outpatient procedures due to COVID and drug price reductions offset those gains. The...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us